Subbu Nambi

Stock Analyst at Guggenheim

(0)
# 4194
Out of 5,327 analysts
36
Total ratings
36.36%
Success rate
-10.22%
Average return
20 Stocks
Name Action PT Current % Upside Ratings Updated
DHR Danaher
Reiterates: Buy
250 250
197.32 26.7% 1 Apr 23, 2025
CYRX CryoPort
Reiterates: Buy
10 10
5.78 73.01% 1 Apr 16, 2025
EXAS Exact Sciences
Reiterates: Buy
60 60
45.52 31.81% 2 Apr 11, 2025
NEOG Neogen
Maintains: Buy
15 13
n/a n/a 2 Apr 10, 2025
MYGN Myriad Genetics
Downgrades: Neutral
n/a
n/a n/a 2 Apr 9, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
45 37
32.23 14.8% 3 Apr 9, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
n/a
n/a n/a 2 Feb 25, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
n/a
n/a n/a 3 Feb 24, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
56 56
48.23 16.11% 5 Feb 24, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
170 150
77.37 93.87% 2 Feb 7, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
170 200
153.71 30.12% 2 Jan 17, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Neutral
n/a
n/a n/a 1 Oct 17, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
6
3.13 91.69% 1 Jun 27, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
6
0.69 769.57% 1 Jun 27, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 3 Jun 26, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Neutral
n/a
n/a n/a 1 Jun 18, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
53
40.16 31.97% 1 Jun 5, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
25
20.67 20.95% 1 Dec 14, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Neutral
n/a
n/a n/a 1 Dec 14, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Neutral
n/a
n/a n/a 1 Dec 14, 2023